Treating Neurodegenerative Diseases Drug Combination is Key

Author: Neurotherapeutics
Published: 2009/01/31
Topic: Medical Research News - Publications List

Page Content: Synopsis - Introduction - Main

Synopsis: Combining the benefits of multiple drugs in a single pill may hold the key to treating neurodegenerative diseases.

Introduction

Combining the benefits of multiple drugs in a single pill may hold the key to treating neurodegenerative diseases, Medical College of Georgia researchers say. Drugs that protect neurons, for example, can be used with those targeting memory to make real progress in treating diseases such as Alzheimer's,

Main Item

Combining the benefits of multiple drugs in a single pill may hold the key to treating neurodegenerative diseases, Medical College of Georgia researchers say.

Drugs that protect neurons, for example, can be used with those targeting memory to make real progress in treating diseases such as Alzheimer's, says Dr. Jerry Buccafusco, founding director of the MCG Alzheimer's Research Center.

"We realize that with neurodegenerative diseases there will not be one magic bullet," Dr. Buccafusco says. "Developing new therapeutics will require an attack on many different levels. But, right now, there are no FDA-approved compounds out there that are significantly disease-modifying. We're at the point where we're just getting to that."

His review of trends in pharmacological research of neurodegenerative diseases is the featured article in the January issue of Neuro-Therapeutics, the journal of the American Society for Experimental Neuro-Therapeutics.

Alzheimer's treatment, for instance, should combine molecules that protect neurons from plaque buildup with approved therapies like cholinesterase inhibitors, which treat cognition and memory loss, Dr. Buccafusco says.

Dr. Buccafusco also cited several novel drug candidates developed at the MCG Alzheimer's Research Center, including two molecules prevent cell death in the brain and improve cognition, reaction time and attention.

"What we have to do now is look at drugs that have already been developed to address very specific disease targets and come up with new ways to combine constituent groups of active molecules into a single therapeutic agent," Dr. Buccafusco says. "Drugs should target more than one particular molecular structure and molecular receptor in the central nervous system. The technology is available to design molecules that have multiple properties all in one package. This approach could represent a new frontier for pharmacology."

Advantages to multi-functional drug compounds, he says, include fewer side effects.

Explore Similar Topics

- Molecular map of the human body and its complex physiological processes based on analysis of molecules in blood, urine and saliva samples.

- In reality moderate drinking likely does not extend people's lives and carries potential health hazards including increased risks of certain cancers.

Citing Information and Page References

Disabled World (DW) is a comprehensive online resource providing information and news related to disabilities, assistive technologies, and accessibility. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.

Cite This Page (APA): Neurotherapeutics. (2009, January 31). Treating Neurodegenerative Diseases Drug Combination is Key. Disabled World (DW). Retrieved February 12, 2025 from www.disabled-world.com/news/research/neurodegenerative-diseases.php

Permalink: <a href="https://www.disabled-world.com/news/research/neurodegenerative-diseases.php">Treating Neurodegenerative Diseases Drug Combination is Key</a>: Combining the benefits of multiple drugs in a single pill may hold the key to treating neurodegenerative diseases.

While we strive to provide accurate and up-to-date information, it's important to note that our content is for general informational purposes only. We always recommend consulting qualified healthcare professionals for personalized medical advice. Any 3rd party offering or advertising does not constitute an endorsement.